FR2243702B1 - - Google Patents

Info

Publication number
FR2243702B1
FR2243702B1 FR7431417A FR7431417A FR2243702B1 FR 2243702 B1 FR2243702 B1 FR 2243702B1 FR 7431417 A FR7431417 A FR 7431417A FR 7431417 A FR7431417 A FR 7431417A FR 2243702 B1 FR2243702 B1 FR 2243702B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7431417A
Other versions
FR2243702A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
Original Assignee
University of Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow filed Critical University of Glasgow
Publication of FR2243702A1 publication Critical patent/FR2243702A1/fr
Application granted granted Critical
Publication of FR2243702B1 publication Critical patent/FR2243702B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7431417A 1973-09-18 1974-09-17 Expired FR2243702B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43642/73A GB1486186A (en) 1973-09-18 1973-09-18 Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection

Publications (2)

Publication Number Publication Date
FR2243702A1 FR2243702A1 (fr) 1975-04-11
FR2243702B1 true FR2243702B1 (fr) 1977-11-04

Family

ID=10429675

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7431417A Expired FR2243702B1 (fr) 1973-09-18 1974-09-17

Country Status (11)

Country Link
US (1) US3966907A (fr)
JP (1) JPS5726484B2 (fr)
BE (1) BE820042A (fr)
CA (1) CA1039187A (fr)
CH (1) CH609091A5 (fr)
DE (1) DE2444299A1 (fr)
DK (1) DK143437C (fr)
FR (1) FR2243702B1 (fr)
GB (1) GB1486186A (fr)
NL (1) NL7412352A (fr)
SE (1) SE421268B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034081A (en) * 1973-09-18 1977-07-05 University Of Glasgow Vaccines against feline leukemia
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
US4264587A (en) * 1979-08-01 1981-04-28 Pedersen Niels C Vaccine for preventing persistent feline leukemia viremia in cats
US4332793A (en) * 1979-12-18 1982-06-01 The Ohio State University Research Foundation Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US5152982A (en) * 1984-03-26 1992-10-06 Chiron Corporation Compositions and methods for FeLV vaccination
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US5374424A (en) * 1986-10-03 1994-12-20 Miles Inc. Multivalent felv-infected feline vaccine
US5306493A (en) * 1986-10-03 1994-04-26 Miles Inc. FeLV-infected feline cell line
EP0377842B1 (fr) * 1988-12-13 1995-10-04 President And Fellows Of Harvard College Isolats FeLV prototypes, pour utilisation comme modèles de maladie, ou comme vaccins
US9783785B2 (en) 2010-12-20 2017-10-10 Cameron K. Tebbi Screening methods for detection of susceptibility to leukemia and lymphomas

Also Published As

Publication number Publication date
AU7336174A (en) 1976-03-25
DK143437C (da) 1981-12-28
BE820042A (fr) 1975-03-18
DE2444299A1 (de) 1975-04-10
GB1486186A (en) 1977-09-21
JPS50116629A (fr) 1975-09-12
US3966907A (en) 1976-06-29
SE7411672L (fr) 1975-03-19
DK489874A (fr) 1975-05-20
FR2243702A1 (fr) 1975-04-11
CA1039187A (fr) 1978-09-26
JPS5726484B2 (fr) 1982-06-04
SE421268B (sv) 1981-12-14
NL7412352A (nl) 1975-03-20
CH609091A5 (fr) 1979-02-15
DK143437B (da) 1981-08-24

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
FR2243702B1 (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AR199451A1 (fr)
AU471461B2 (fr)
AR195948A1 (fr)
AR195311A1 (fr)
AR193950A1 (fr)
AU447540B2 (fr)
AU461342B2 (fr)
AR201432A1 (fr)
AR210729A1 (fr)
AR196382A1 (fr)
AU1891376A (fr)
AR196212Q (fr)
AR196123Q (fr)
AU470923A (fr)
AU479539A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse